No Added Value to Spironolactone in Acute HF: ATHENA-HF No Added Value to Spironolactone in Acute HF: ATHENA-HF

"It was a totally neutral trial," maybe because it looked at the wrong end points or because the role of diuretic resistance in such patients is misunderstood, according to some.Heartwire from Medscape
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news